Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Interest Coverage Ratio (2022 - 2025)

Historic Interest Coverage Ratio for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to 18.61.

  • Centessa Pharmaceuticals' Interest Coverage Ratio fell 255.8% to 18.61 in Q3 2025 from the same period last year, while for Sep 2025 it was 19.21, marking a year-over-year decrease of 2098.16%. This contributed to the annual value of 19.93 for FY2024, which is 1524.12% down from last year.
  • As of Q3 2025, Centessa Pharmaceuticals' Interest Coverage Ratio stood at 18.61, which was down 255.8% from 18.95 recorded in Q2 2025.
  • Over the past 5 years, Centessa Pharmaceuticals' Interest Coverage Ratio peaked at 10.7 during Q1 2025, and registered a low of 41.39 during Q2 2022.
  • Its 4-year average for Interest Coverage Ratio is 21.27, with a median of 18.88 in 2022.
  • As far as peak fluctuations go, Centessa Pharmaceuticals' Interest Coverage Ratio soared by 5363.02% in 2023, and later crashed by 11979.0% in 2024.
  • Over the past 4 years, Centessa Pharmaceuticals' Interest Coverage Ratio (Quarter) stood at 18.88 in 2022, then grew by 27.52% to 13.69 in 2023, then plummeted by 119.79% to 30.08 in 2024, then skyrocketed by 38.13% to 18.61 in 2025.
  • Its last three reported values are 18.61 in Q3 2025, 18.95 for Q2 2025, and 10.7 during Q1 2025.